Additional value of PCA3 density to predict initial prostate biopsy outcome

被引：0
|
作者：
A. Ruffion
P. Perrin
M. Devonec
D. Champetier
M. Decaussin
P. Paparel
V. Vlaeminck-Guillem
机构：
[1] Hospices Civils de Lyon,Service d’Urologie, Centre Hospitalier Lyon Sud
[2] Université de Lyon,Faculté de Médecine
[3] Université Claude Bernard Lyon 1,Institut de Génomique Fonctionnelle de Lyon, CNRS UMR5242
[4] Université de Lyon,Service d’Anatomie et de Cytologie Pathologiques, Centre Hospitalier Lyon Sud
[5] Université Lyon 1,Unité Médicale d’Oncologie Moléculaire et Transfert, Service de Biochimie biologie moléculaire sud, Centre Hospitalier Lyon Sud
[6] Hospices Civils de Lyon,Centre de Recherche en Cancérologie de Lyon
[7] Hospices Civils de Lyon, INSERM 1052 CNRS 5286
[8] Centre Léon Bérard,undefined
来源：
World Journal of Urology | 2014年 / 32卷
关键词：
Prostate cancer; Tumor markers; Urine; PSA; PSA density; Prostate cancer gene 3;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：917 / 923
页数：6
相关论文
共 50 条
  • [31] NEGATIVE PREDICTIVE VALUE OF PROSTATE CANCER ANTIGEN 3 (PCA3)
    Marley, Ciara S.
    Siegrist, Timothy C.
    Armenakas, Noel A.
    Fracchia, John A.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 656 - 657
  • [32] Urinary PCA3 to predict prostate cancer in a cohort of 1015 patients
    Vlaeminck-Guillem, V.
    Devonec, M.
    Champetier, D.
    Decaussi-Petrucci, M.
    Paparel, P.
    Perrin, P.
    Ruffion, A.
    PROGRES EN UROLOGIE, 2015, 25 (16): : 1160 - 1168
  • [33] PCA3 urine assay for prostate cancer in Japanese men undergoing prostate biopsy
    Okihara, K.
    Ochial, A.
    Fros, Z.
    Miki, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] A COMPARISON BETWEEN MULTIPARAMETRIC MRI, PCA3, AND PHI IN THE PREDICTION OF PROSTATE CANCER AFTER AN INITIAL NEGATIVE BIOPSY
    Porpiglia, Francesco
    Russo, Filippo
    Manfredi, Matteo
    Mele, Fabrizio
    Grande, Susanna
    Fiori, Cristian
    Cattaneo, Giovanni
    Garrou, Diletta
    Amparore, Daniele
    Bollito, Enrico
    Papotti, Mauro
    Regge, Daniele
    ANTICANCER RESEARCH, 2014, 34 (05) : 2670 - 2670
  • [35] Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3; a systematic analysis of expert opinion
    Tombal, Bertrand
    Ameye, Filip
    de la Taille, Alexandre
    de Reijke, Theo
    Gontero, Paolo
    Haese, Alexander
    Kil, Paul
    Perrin, Paul
    Remzi, Mesut
    Schroeder, Joerg
    Speakman, Mark
    Volpe, Alessandro
    Meesen, Bianca
    Stoevelaar, Herman
    WORLD JOURNAL OF UROLOGY, 2012, 30 (02) : 251 - 256
  • [36] Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3; a systematic analysis of expert opinion
    Bertrand Tombal
    Filip Ameye
    Alexandre de la Taille
    Theo de Reijke
    Paolo Gontero
    Alexander Haese
    Paul Kil
    Paul Perrin
    Mesut Remzi
    Jörg Schröder
    Mark Speakman
    Alessandro Volpe
    Bianca Meesen
    Herman Stoevelaar
    World Journal of Urology, 2012, 30 : 251 - 256
  • [37] EXTERNAL VALIDATION OF A PCA3-BASED INITIAL BIOPSY NOMOGRAM TO PREDICT PROSTATE BIOPSY OUTCOME WITHIN TWO INDEPENDENT VALIDATION COHORTS
    Hansen, Jens
    Ferro, Matteo
    Becker, Andreas
    Fisch, Margit
    Terraciano, Daniela
    Steuber, Thomas
    Graefen, Markus
    Haese, Alexander
    Altieri, Vincenzo
    Perdona, Sisto
    Chun, Felix K-H
    JOURNAL OF UROLOGY, 2013, 189 (04): : E841 - E842
  • [38] PCA3 PREDICTS PROSTATE BIOPSY OUTCOME IN MEN RECEIVING DUTASTERIDE: RESULTS FROM THE DUTASTERIDE REDUCE TRIAL
    Andriole, Gerald
    Aubin, Sheila
    Reid, Jennifer
    Sarno, Mark
    Blase, Amy
    Aussie, Jacqueline
    Rittenhouse, Harry
    Rittmaster, Roger
    Groskopf, Jack
    JOURNAL OF UROLOGY, 2010, 183 (04): : E801 - E801
  • [39] PCA3 PREDICTS PROSTATE BIOPSY OUTCOME IN MEN RECEIVING DUTASTERIDE: RESULTS FROM THE DUTASTERIDE REDUCE TRIAL
    Andriole, G.
    Aubin, S. M. J.
    Reid, J.
    Samo, M. J.
    Blase, A.
    Aussie, J.
    Rittenhouse, H.
    Roger, R.
    Groskopf, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 306 - 306
  • [40] Comparison of PHI (Prostate Health Index) and PCA3 assay in the prediction of prostate biopsy (PBx) outcome in patients who have undergone initial and repeated prostatic biopsies
    Scattoni, V
    Lazzeri, M.
    De Luca, S.
    Bollito, E.
    Randone, D.
    Lughezzani, G.
    Larcher, A.
    Lista, G.
    Gadda, G.
    Maccagnano, C.
    Rigatti, P.
    Guazzoni, G.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E912 - U917
12345